QuidelOrtho (QDEL) director Ann D. Rhoads granted 19,599 RSUs in lieu of cash fees

Filing Impact

(Neutral)

Filing Sentiment

(Neutral)

Form Type

Rhea-AI Filing Summary

QuidelOrtho Corp director Ann D. Rhoads reported three equity compensation awards in the form of restricted stock units (RSUs). On June 25, 2026, she was granted 369 RSUs labeled as premium units, 3,698 RSUs labeled as converted units, and 15,532 RSUs as an equity grant, each representing one share of common stock when delivered.

The RSUs carry a stated value of $0.00 per unit because they are compensation awards rather than market purchases. One RSU tranche will vest on June 25, 2027, and another tranche is scheduled to vest in stages: 924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares on December 25, 2026, and 925 shares on March 25, 2027.

The filing explains that these RSUs were received in lieu of cash payments for certain retainer and Board service-related fees under a deferred compensation program for non-employee directors, with release of vested units following the director’s elected deferral schedule.

Insider Trade Summary

3 transactions reported

Mixed 3 txns

Insider RHOADS ANN D

Role null

Type	Security	Shares	Price	Value
Grant/Award	Restricted Stock Units (Equity Grant)	15,532	$0.00	--
Grant/Award	Restricted Stock Units (Converted)	3,698	$0.00	--
Grant/Award	Restricted Stock Units (Premium)	369	$0.00	--

Holdings After Transaction: Restricted Stock Units (Equity Grant) — 15,532 shares (Direct, null); Restricted Stock Units (Converted) — 3,698 shares (Direct, null); Restricted Stock Units (Premium) — 369 shares (Direct, null)

Footnotes (1)

Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock. The restricted stock units will vest on June 25, 2027. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule. 924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027.

Key Figures

Premium RSU grant: 369 units Converted RSU grant: 3,698 units Equity grant RSUs: 15,532 units +3 more

6 metrics

Premium RSU grant 369 units Restricted Stock Units (Premium) granted June 25, 2026

Converted RSU grant 3,698 units Restricted Stock Units (Converted) granted June 25, 2026

Equity grant RSUs 15,532 units Restricted Stock Units (Equity Grant) granted June 25, 2026

Total RSUs granted 19,599 units Sum of three RSU awards on June 25, 2026

Single vesting date June 25, 2027 One RSU tranche vests on this date

Staged vesting amounts 924, 924, 925, 925 shares Vesting on Jun 25 2026, Sep 25 2026, Dec 25 2026, Mar 25 2027

Key Terms

Restricted Stock Units, deferred compensation program, retainer and Board of Director service-related fees, vest, +1 more

5 terms

Restricted Stock Units financial

"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

deferred compensation program financial

"under a deferred compensation program applicable to participating non-employee directors."

vest financial

"The restricted stock units will vest on June 25, 2027."

A vest is the process by which an employee earns the right to receive certain benefits or ownership interests, such as stock or retirement funds, over time. It’s similar to earning a reward gradually, ensuring that the benefit becomes fully yours only after a set period or meeting specific conditions. This makes it important for investors because it determines when they can actually claim or use those benefits.

restricted stock unit financial

"Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock."

A restricted stock unit is a promise from a company to give an employee shares of stock after certain conditions are met, like staying with the company for a set amount of time. It’s like earning a bonus that turns into company stock once you’ve proven your commitment, making it a way to motivate and reward employees.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google

Form 4 Insider Transactions: What Each Field Means →

Available on EDGAR 06/29/2026 - 06:00 PM Accepted by SEC EDGAR 06/29/2026 - 05:59 PM

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

RHOADS ANN D

(Last)

(First)

(Middle)

9975 SUMMERS RIDGE ROAD

(Street)

SAN DIEGO

CALIFORNIA

92121

(City)

(State)

(Zip)

UNITED STATES

(Country)

2. Issuer Name and Ticker or Trading Symbol
QuidelOrtho Corp [ QDEL ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director	10% Owner
	Officer (give title below)	Other (specify below)

2a. Foreign Trading Symbol

3. Date of Earliest Transaction (Month/Day/Year)
06/25/2026

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

4. If Amendment, Date of Original Filed (Month/Day/Year)

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	Amount	(A) or (D)	Price		6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares	8. Price of Derivative Security (Instr. 5)		10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
Restricted Stock Units (Equity Grant)	⁽¹⁾	06/25/2026		A		15,532		⁽²⁾	⁽²⁾	Common Stock	15,532	$0	15,532	D
Restricted Stock Units (Converted)	⁽¹⁾	06/25/2026		A		3,698		⁽³⁾⁽⁴⁾	⁽³⁾⁽⁴⁾	Common Stock	3,698	$0	3,698	D
Restricted Stock Units (Premium)	⁽¹⁾	06/25/2026		A		369		⁽²⁾⁽³⁾	⁽²⁾⁽³⁾	Common Stock	369	$0	369	D

Explanation of Responses:

1. Each restricted stock unit represents the right to receive one share of QuidelOrtho Corporation common stock.

2. The restricted stock units will vest on June 25, 2027.

3. The restricted stock units were received in lieu of cash payments to the reporting person for certain retainer and Board of Director service-related fees under a deferred compensation program applicable to participating non-employee directors. Release of vested restricted stock units will occur according to the elected deferral schedule.

4. 924 shares vested on June 25, 2026, 924 shares will vest on September 25, 2026, 925 shares will vest on December 25, 2026, and 925 shares will vest on March 25, 2027.

Remarks:

	/s/ Phillip S. Askim, attorney-in-fact for Ann D. Rhoads	06/29/2026
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 4: SEC 1474 (03-26)

Source: View Original Filing on SEC EDGAR

FAQ

What insider transactions did QuidelOrtho (QDEL) disclose for Ann D. Rhoads?

QuidelOrtho disclosed that director Ann D. Rhoads received three grants of restricted stock units totaling 19,599 units on June 25, 2026. These awards are equity-based compensation rather than open-market stock purchases or sales.

How many restricted stock units did Ann D. Rhoads receive from QuidelOrtho (QDEL)?

Ann D. Rhoads received 369 premium RSUs, 3,698 converted RSUs, and 15,532 equity grant RSUs. Each unit represents the right to receive one share of QuidelOrtho common stock when it is ultimately delivered.

When do Ann D. Rhoads’ QuidelOrtho (QDEL) restricted stock units vest?

One tranche of restricted stock units will vest on June 25, 2027. Another tranche vests in stages: 924 shares on June 25, 2026, 924 on September 25, 2026, 925 on December 25, 2026, and 925 on March 25, 2027.

Why did Ann D. Rhoads receive QuidelOrtho (QDEL) RSUs instead of cash?

The filing states the RSUs were received in lieu of cash payments for certain retainer and Board service-related fees. They were granted under a deferred compensation program available to participating non-employee directors at QuidelOrtho.

Do Ann D. Rhoads’ QuidelOrtho (QDEL) RSU grants involve any stock sales?

No stock sales are reported in this filing. All three transactions are coded as awards or other acquisitions of derivative securities, reflecting equity compensation grants rather than open-market buying or selling of QuidelOrtho common shares.

How will Ann D. Rhoads receive shares from her QuidelOrtho (QDEL) RSUs?

Each restricted stock unit corresponds to one share of QuidelOrtho common stock. Once the units vest, the release and delivery of shares will follow the deferral schedule she elected under the company’s deferred compensation program.